Cargando…

Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy

Intravitreal bevacizumab (Avastin) use in preterm infants with retinopathy of prematurity is associated with severe neurological disabilities, suggesting vascular leakage. We examined the hypothesis that intermittent hypoxia (IH) potentiates intravitreal Avastin leakage. Neonatal rats at birth were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Jeffrey J., Cai, Charles L., Shrier, Eric M., McNally, Lois, Lazzaro, Douglas R., Aranda, Jacob V., Beharry, Kay D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523466/ https://www.ncbi.nlm.nih.gov/pubmed/28770109 http://dx.doi.org/10.1155/2017/4353129

Ejemplares similares

Oxygen-Induced Retinopathy from Recurrent Intermittent Hypoxia Is Not Dependent on Resolution with Room Air or Oxygen, in Neonatal Rats
por: Beharry, Kay D., et al.
Publicado: (2018)

Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy
por: Aranda, Jacob V., et al.
Publicado: (2016)

Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells
por: Yazdanyar, Amirfarbod, et al.
Publicado: (2023)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Dose Response of Bumetanide on Aquaporins and Angiogenesis Biomarkers in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia
por: Guzel, Sibel, et al.
Publicado: (2021)

Renal biomarkers of acute kidney injury in response to increasing intermittent hypoxia episodes in the neonatal rat
por: Zangaladze, Anano, et al.
Publicado: (2021)

Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
por: Bazvand, Fatemeh, et al.
Publicado: (2021)

NEONATAL INTERMITTENT HYPOXIA, FISH OIL AND/OR ANTIOXIDANT SUPPLEMENTATION ON GUT MICROBIOTA IN NEONATAL RATS
por: Bodkin, Darren, et al.
Publicado: (2022)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhy, Srikant, et al.
Publicado: (2018)

Combination Antioxidant/NSAID Therapies and Oral/Topical Ocular Delivery Modes for Prevention of Oxygen-Induced Retinopathy in a Rat Model
por: Beharry, Kay D., et al.
Publicado: (2020)

Pharmacodynamic Effects of Standard versus High Caffeine Doses in the Developing Brain of Neonatal Rats Exposed to Intermittent Hypoxia
por: Soontarapornchai, Kutilda, et al.
Publicado: (2021)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
por: Shrestha, Ruchi, et al.
Publicado: (2019)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy
por: Guzel, Sibel, et al.
Publicado: (2020)

Comparison of coenzyme Q10 or fish oil for prevention of intermittent hypoxia-induced oxidative injury in neonatal rat lungs
por: D’Agrosa, Christina, et al.
Publicado: (2021)

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
por: Arevalo, J. Fernando, et al.
Publicado: (2011)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
por: Minami, Tsuyoshi, et al.
Publicado: (2014)

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
por: Pawar, Neelam, et al.
Publicado: (2023)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019)

The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy
por: Nitta, Fumihiko, et al.
Publicado: (2014)

Co-Enzyme Q10 and n-3 Polyunsaturated Fatty Acid Supplementation Reverse Intermittent Hypoxia-Induced Growth Restriction and Improved Antioxidant Profiles in Neonatal Rats
por: Beharry, Kay D., et al.
Publicado: (2017)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity
por: Tokgöz, Orhan, et al.
Publicado: (2013)

Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy
por: Brito, Isis A. S., et al.
Publicado: (2015)

The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
por: Al-Kharashi, Abdullah, et al.
Publicado: (2016)

Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity
por: Karkhaneh, Reza, et al.
Publicado: (2018)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
por: Mansour, Ahmad M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dh0rmekig6lfm0sps0bgoep2uo